SEC Form D private-offering filing

Amani Therapeutics, Inc.

Name: Amani Therapeutics, Inc. - new SEC Form D private-offering filing, New York, NY
Published: 2025-12-10

A new SEC Form D private-offering notice from New York, NY, a $31,120,000 filer-stated offering target in Biotech. The source filing is one click away.

Amani Therapeutics, Inc. site↗ Verified via SEC Form D

Biotech developing AM-01, a fixed dose combination therapy pairing clozapine with a novel compound to treat treatment resistant schizophrenia.

Filed 2025-12-10Filed to raise $31,120,000First money in 2025-11-25Raised so far $31,120,000HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified amanitx.com↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.